Vizirgianakis Stavros G.
SEC CIK 1559834 · EDGAR
BoughtSold
Most active insiders at XTNT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | JAIN ABHINAV | Dir | — | — |
| 2 | Beeson Jonn R. | Dir | — | — |
| 3 | Schallenberger Mark A. | COO | — | — |
| 4 | Neils Scott C | CFO, Assistant Sec | — | — |
| 5 | Browne Sean E | Pres, CEO, Dir | — | — |
| 6 | Vizirgianakis Stavros G. | Dir | — | — |
| 7 | Lipschultz Tyler | Dir | — | — |
| 8 | BAKEWELL JOHN K | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 18:09 | 2026-08-15 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +323.3K | 7.84M | +4% | $0 | |
| 2026-06-15 19:00 | 2026-06-11 | APYX | Apyx Medical Corp | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +450.0K | 2.20M | +26% | $0 | |
| 2025-11-18 | 2025-11-15 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +553.8K | 7.52M | +8% | $0 | |
| M | 2024-08-19 | 2024-08-15 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +748.6K | 6.46M | +13% | $0 |
| D | 2023-08-17 | 2023-08-15 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +217.8K | 6.21M | +4% | $0 |
| 2022-11-17 | 2022-11-15 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +144.6K | 6.00M | +2% | $0 | |
| D | 2022-10-11 | 2022-10-07 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | P - Purchase | $0.48 | +2.26M | 5.85M | +63% | +$1.09M |
| 2022-08-26 | 2022-08-25 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +70.8K | 3.59M | +2% | $0 | |
| D | 2022-06-22 | 2022-06-16 | BVS | Bioventus Inc. | Vizirgianakis Stavros G. | Dir | M - OptEx | $0.00 | +965 | 2.78M | +0.0% | $0 |
| 2022-04-28 | 2021-10-29 | BVS | Bioventus Inc. | Vizirgianakis Stavros G. | Dir | A - Grant | — | +2.78M | 2.78M | New | — |
Purchase Sale Sale after option exercise All abbreviations